Anti-Laminin-2 LG5 [C3_Hu10], Human IgG1, kappa
Applications | ELISA, FC, IF, WB |
Reactivities | Human, Mouse |
Anti-Laminin-2 LG5 [C3_Hu10], Human IgG1, kappa
Applications | ELISA, FC, IF, WB |
Reactivities | Human, Mouse |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
Applications | ELISA, FC, WB |
Reactivities | Human |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
Applications | Bl, FC, IHC |
Reactivities | Human |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Anti-NKp46 [Bab281], Human IgG1, kappa
Applications | FC, IF, IP |
Reactivities | Human, Macaque |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-IL-8 [WS-4], Human IgG1, kappa
Applications | ELISA, IHC, Neutralize |
Reactivities | Human, Rabbit |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-His tag (C-term) (Clone 3D5)
Applications | ELISA, WB |
Conjugation | Unconjugated |
Recombinant Anti-PD-L1 (Clone 332M7)
Applications | Bl, FC |
Reactivities | Human, Mouse, Monkey |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
Applications | ELISA, IF |